Gordon Ross is a Senior Applications Scientist with Agilent Technologies based near Manchester, UK. He leads a team of applications scientists and is responsible for the Agilent Centre of Excellence Demonstration Facility in Cheadle, UK.
After obtaining a BSc from University of Glasgow, Gordon went on to work in St Bartholomew’s Hospital and Medical College, University of London, as a Research Assistant and later as a Senior Biochemist,
There, he worked on the development of various bioanalytical techniques, including HPLC, for use in the investigation of endocrine function and the diagnosis of endocrine disease. During this time he gained a MSc in Analytical Chemistry from Birkbeck College, University of London. In 1989, together with Prof. David Perrett, of the Medical Professorial Unit at Bart’s, Gordon began studies on the use of the then novel technique of Capillary Electrophoresis (CE) in the analysis and characterisation of haemoglobin in normal and diseased states, and the analysis of drugs and endogenous compounds in biofluids; these studies formed the basis of his doctoral thesis.
Having successfully obtained his doctorate, Gordon went on to work for Hewlett-Packard (now Agilent Technologies) based in Germany and worked in the development, marketing and support of Capillary Electrophoresis applications. He has has lectured on CE, CEC, CE/MS, LC and LC/MS throughout the world and has published, over 40 peer reviewed papers, invited and other publications, including two book chapters. In 1998 Gordon was invited by the United States Pharmacopoeia Committee of Revision, as an expert on CE, to become a member of the Expert Working Group for preparing the general chapter on CE for the US Pharmacopoeia.
Since 2001 Gordon has been based in UK working on demonstration, development and support of CE/MS and LC/MS applications using Single Quadrupole, Ion Trap, Triple Quad, TOF and QTOF instruments. He maintains his clinical interests working with external collaborations in the growing field of Clinical Metabolomics and is an industrial supervisor for 3 PhD students at different Universities in UK. More recently he has promoted the definition and implementation of screening workflows using TOF technology in various fields from environmental to food to forensic analysis. It is this effort which has led him into an interest in the screening and analysis of extractable and leachable compounds in the environmental, food, manufacturing and bio/pharmaceutical arenas.